Cargando…
Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas
Programmed cell death-ligand 1(PD-L1) was expressed in various malignancies, and interaction with its receptor programmed cell death 1 (PD-1) often contributed to immune evasion of tumor cells. In this study, we explored the expression of PD-L1 and its correlation with clinical outcomes in gliomas....
Autores principales: | Zeng, Jing, Zhang, Xin-Ke, Chen, Hua-Dong, Zhong, Zhi-Hai, Wu, Qiu-Liang, Lin, Su-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891016/ https://www.ncbi.nlm.nih.gov/pubmed/26771840 http://dx.doi.org/10.18632/oncotarget.6884 |
Ejemplares similares
-
The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes
por: Ding, Xing-Chen, et al.
Publicado: (2020) -
Expression of programmed death ligand-1 and programmed death-1 in samples of invasive ductal carcinoma of the breast and its correlation with prognosis
por: Zhou, Tingting, et al.
Publicado: (2018) -
The Clinical and Biomarker Association of Programmed Death Ligand 1 and its Spatial Heterogeneous Expression in Colorectal Cancer
por: Wei, Xiao-Li, et al.
Publicado: (2018) -
Programmed cell death‐ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics
por: Mou, Haibo, et al.
Publicado: (2021) -
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma
por: Jiang, Li, et al.
Publicado: (2015)